Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Updated . What changed?
Amesite Inc is a software-application business based in the US. Amesite shares (AMST) are listed on the NASDAQ and all prices are listed in US Dollars. Amesite employs 12 staff and has a trailing 12-month revenue of around USD$236,363.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | USD$3.79 - USD$8.932 |
---|---|
50-day moving average | USD$5.2963 |
200-day moving average | USD$4.8221 |
Wall St. target price | USD$7 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | N/A |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revenue TTM | USD$236,363 |
---|---|
Gross profit TTM | USD$59,749 |
Return on assets TTM | -34.37% |
Return on equity TTM | -95.06% |
Profit margin | 0% |
Book value | N/A |
Market capitalisation | USD$144.2 million |
TTM: trailing 12 months
There are currently 11,081 Amesite shares held short by investors – that's known as Amesite's "short interest". This figure is 20.9% down from 14,013 last month.
There are a few different ways that this level of interest in shorting Amesite shares can be evaluated.
Amesite's "short interest ratio" (SIR) is the quantity of Amesite shares currently shorted divided by the average quantity of Amesite shares traded daily (recently around 138512.5). Amesite's SIR currently stands at 0.08. In other words for every 100,000 Amesite shares traded daily on the market, roughly 80 shares are currently held short.
To gain some more context, you can compare Amesite's short interest ratio against those of similar companies.
However Amesite's short interest can also be evaluated against the total number of Amesite shares, or, against the total number of tradable Amesite shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amesite's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Amesite shares in existence, roughly 0 shares are currently held short) or 0.0011% of the tradable shares (for every 100,000 tradable Amesite shares, roughly 1 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Amesite.
Find out more about how you can short Amesite stock.
We're not expecting Amesite to pay a dividend over the next 12 months.
You may also wish to consider:
Amesite Inc., an artificial intelligence driven platform and course designer, provides online products and services in the United States. It serves businesses, universities and colleges, and K-12 schools. The company is headquartered in Detroit, Michigan.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.